Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity

Documenti analoghi

• Influence of lipophilicity on the antibacterial activity of polymyxin derivatives and on their ability to act as potentiators of rifampicin
  di: Brown, Pamela, et al.
  Pubblicazione: (2021)
• Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206
  di: Brown, Pamela, et al.
  Pubblicazione: (2019)
• Antibacterial Activity of Fluorobenzoylthiosemicarbazides and Their Cyclic Analogues with 1,2,4-Triazole Scaffold
  di: Kosikowska, Urszula, et al.
  Pubblicazione: (2020)
• Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery
  di: Escano, Jerome, et al.
  Pubblicazione: (2017)
• Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides.
  di: Head, S, et al.
  Pubblicazione: (1990)